Filing Details

Accession Number:
0001209191-21-020926
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-16 17:11:40
Reporting Period:
2021-03-15
Accepted Time:
2021-03-16 17:11:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1419600 Flexion Therapeutics Inc FLXN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1806204 Melissa Layman C/O Flexion Therapeutics, Inc.
10 Mall Road, Suite 301
Burlington MA 01803
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-03-15 4,520 $11.80 103,956 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to the Reporting Person on April 1, 2020.